Related references
Note: Only part of the references are listed.Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study
Maximilian Stahl et al.
LEUKEMIA (2020)
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
Rory M. Shallis et al.
LEUKEMIA & LYMPHOMA (2020)
Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits
Rory M. Shallis et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis
Jan P. Bewersdorf et al.
TRANSFUSION (2020)
Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia
Morgan L. Trepte et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study
Min Hyuk Choi et al.
TRANSFUSION (2018)
Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit
Stephen M. Pastores et al.
CANCER (2018)
Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large US web-based survey*
Maximilian Stahl et al.
LEUKEMIA & LYMPHOMA (2018)
Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis
Sarah Bertoli et al.
LEUKEMIA RESEARCH (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Kelly J. Norsworthy et al.
LEUKEMIA RESEARCH (2017)
Management of Hyperleukocytosis
Antonio Ruggiero et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia
Anne-Claire Mamez et al.
LEUKEMIA & LYMPHOMA (2016)
How I treat hyperleukocytosis in acute myeloid leukemia
Christoph Roellig et al.
BLOOD (2015)
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis
Kevin H. M. Kuo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis
Sapna Oberoi et al.
LEUKEMIA RESEARCH (2014)
Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia
Nicole Aqui et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
Hyperleukocytosis, leukostasis and leukapheresis: Practice management
Chezi Ganzel et al.
BLOOD REVIEWS (2012)
Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia
Margaret T. Kasner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: No impact on early mortality and intracranial hemorrhage
Ming-Chih Chang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Management of hyperleukocytosis in acute myelogenous leukemia using hydroxyurea rather than leukopheresis.
Kevin H. M. Kuo et al.
BLOOD (2006)
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome - Predictive prognostic models for outcome
H Kantarjian et al.
CANCER (2006)
Tumour lysis syndrome: new therapeutic strategies and classification
MS Cairo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)
FB Taylor et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Share Paper
